Tumor suppression using placental stem cells

Details for Australian Patent Application No. 2007281920 (hide)

International Classifications

Event Publications

19 March 2009 PCT application entered the National Phase

PCT publication WO2008/019148 Priority application(s): WO2008/019148

23 April 2009 Amendment Made

The nature of the amendment is: Amend the priority details to read from not given to 11/888,926 03 Aug 2007 US 2007282343 Japan as represented by President of National Cardiovascular Center; Asubio Pharma Co., Ltd.; University of Miyazaki The nature of the amendment is: Amend the invention title to read Spinal nerve repair promoting therapeutics containing ghrelin or its derivatives or substances that act on GHS-R1a as an active ingredient

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.